Back

Genetic factors in risk stratification of concealed long QT patients with no history of beta-blocker use

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of arrhythmias Genetic Aspects of Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Aleksei Savelev

Lund (Sweden)

7 More presentations in this session

Presentation thumbnail
Piezo1-Mediated TGF-beta2 autocrine loop promotes atrial fibrosis and fibrillation under pressure overload
Doctor H. Wu (Xi'an, CN)
Abstract Slides Video
Presentation thumbnail
New phenotypic association for SMAD6 gene: its role in the development of cardiac conduction disorders and pulmonary arterial hypertension/hereditary haemorrhagic telangiectasia.
Doctor A. Amor Salamanca (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Elucidation of the pathogenesis in long QT syndrome caused by a CALM2 variant, p.D134H, using knock-in mouse model
Doctor S. Ohno (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Therapeutic effect of selective serotonin reuptake inhibitors to gain-of-function KCND3 variant identified in a patient with early repolarization and refractory epilepsy.
Doctor T. Byambajav (Suita, JP)
Abstract Slides Video
Presentation thumbnail
New genetic risk factor for serious cardiac events in Andersen-Tawil Syndrome - p.Arg71Gln variant in BAG3.
Ms M. Krych (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of arrhythmias

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Evaluation of carriers of pathogenic variants in KCNH2 gene
thumbnail
Congress Presentation
Static and dynamic abnormalities in electromechanical and autonomic cardiac function characterize the proarrhythmic substrate in the long-QT syndrome
thumbnail
Congress Presentation
The usefulness of QT interval measurement as a screening tool for cascade testing in asymptomatic patients at risk of long QT syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources